Former Gen-Probe Chairman and CEO Carl Hull and former Laboratory Corporation of American Chairman and CEO Thomas MacMahon have joined the board of Ortho Clinical Laboratories as independent members.
Hull has more than 30 years of experience in the life sciences and diagnostics markets, and in addition to his stint at Gen-Probe, he held executive positions at Applied Biosystems, Applied Imaging, Ventana Medical Systems, and Abbott Diagnostics.
MacMahon is currently an executive partner at Foundation Medical Partners. He began his career at Roche.
Also joining Ortho Clinical Diagnostics' board as independent members are former Fenwal President and CEO Ron Labrum and Covidien President and CEO José Almeida.